Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Ruxolitinib
Offer reference number: CM/TNS/26/5755
Period of framework: 1 November 2026 to 31 October 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Pipeline notice (UK1). An early signal of a contract the buyer expects to let. Nothing to bid for yet.
Bids are submitted through the buyer’s own portal, not on this site. Read the full notice on Find a Tender before relying on any date here.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Apr 2028 – Mar 2029 | - | planned |
Changes the buyer published to this notice after it first appeared.
Revised timelines as follows:
Period of Framework in Description changed from:
'01 November 2026 to 31 October 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months'
To
'01 April 2028 to 31 March 2029 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months'